Publication

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…

Dorottya Gui-BodnarMay 28, 2026

Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

CertaraMay 26, 2026

Blog

Certainty US 2026 recap: advancing model-informed drug development right from the start

This blog shares the highlights of our US Certainty event and explains how AI-enabled approaches…

CertaraMay 26, 2026

Blog

Why ask your CRO to use Pinnacle 21 Enterprise?

Why sponsors should require CROs to use Pinnacle 21 Enterprise - reduce compliance risk &…

CertaraMay 22, 2026

Blog

Everything You Need to Know About CRFs in Clinical Trials

Read about the basics of CRFs and eCRF design, why annotated CRFs should be standardized…

CertaraMay 22, 2026

Blog

Best Practices for AI Prompt Engineering in Life Sciences

AI prompt engineering is an essential skill for using LLMs. Read our blog for best…

CertaraMay 22, 2026

Publication

Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models

This publication describes the development of an updated population pharmacokinetic (PopPK) model for niraparib, a…

CertaraMay 21, 2026

Poster

Quantitative Systems Pharmacology Modeling of Atopic Dermatitis to Predict Biologic Therapy Response

Explore a quantitative systems pharmacology (QSP) model of atopic dermatitis calibrated to clinical trial data.

CertaraMay 21, 2026

Announcement

Modernizing the Academic Program and Retiring Chemicalize

Find key dates and details about discontinued academic licenses, Chemicalize retirement, and the transition to…

CertaraMay 21, 2026

Video

MIDD is Transforming Drug Development

Recorded live at the US Certainty 2026 client conference in Boston, Certara clients who are…

CertaraMay 21, 2026

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Certainty US 2026 recap: advancing model-informed drug development right from the start

Why ask your CRO to use Pinnacle 21 Enterprise?

Everything You Need to Know About CRFs in Clinical Trials

Best Practices for AI Prompt Engineering in Life Sciences

Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models

Quantitative Systems Pharmacology Modeling of Atopic Dermatitis to Predict Biologic Therapy Response

Modernizing the Academic Program and Retiring Chemicalize

MIDD is Transforming Drug Development

Newsletter sign up

Quick links

Solutions

Contact